Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid.
D000328:Adult; D003550:Cystic Fibrosis / Q000150:complications*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008286:Malabsorption Syndromes / Q000150:complications / Q000188:drug therapy*; D008297:Male; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*; D014810:Vitamin E / Q000493:pharmacokinetics*
D005765:Gastrointestinal Agents; D014810:Vitamin E; D014580:Ursodeoxycholic Acid